Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1158780 · PLUR

Pluri Inc.

Filing with the SEC SEC-reporting company Haifa Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jul 13, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Stockholders’ deficitAt the end of 2025 stockholders’ equity was negative: −$14.6M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $22.6M for the year (2024: $21.3M).
  • Private capital raiseOn Sep 4, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$1.3M$326K
Net income (loss)−$22.6M$21.3M
Total assets$30.6M$30.9M
Stockholders’ equity−$14.6M−$8M
Cash and equivalents$4.7M$7.2M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends June 30. Check the annual report for the exact figures and periods.

Name as filed
Pluri Inc.
Formerly: Pluristem Therapeutics Inc
CIK
0001158780
Tickers
PLUR
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Nevada
Business address
Haifa (outside the US)
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
June 30
Last annual report
10-K for the period ended Jun 30, 2026
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 6, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2026
    Form 10-K · filed Sep 10, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Sep 4, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 5.07, 9.01 · filed Jun 22, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2025
    Form 10-Q · filed Feb 12, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 22, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 8.01, 9.01 · filed Dec 9, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 16, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2025
    Form 10-K · filed Sep 17, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 11, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 3.01, 5.02, 5.07 · filed Jul 3, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 5.02, 5.07 · filed Jul 3, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Mar 19, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Feb 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2024
    Form 10-Q · filed Feb 11, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 9.01 · filed Jan 29, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 21, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 27, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2024
    Form 10-K · filed Sep 18, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 23, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 2, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 31, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2023
    Form 10-Q · filed Feb 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 13, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Oct 19, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2023
    Form 10-K · filed Sep 12, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 13, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 9, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 25, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2022
    Form 10-Q · filed Feb 13, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jan 4, 2023 · filing